137 related articles for article (PubMed ID: 15646835)
21. [Prognostic significance and clinic utility of serum and immunohistochemical cathepsin B levels in colorectal cancer].
Padilla D; Cubo T; Molina JM; García M; De la Osa G; Palomino T; Pardo R; Martín J; Arévalo E; Hernández Calvo J
An Med Interna; 2003 Oct; 20(10):521-5. PubMed ID: 14585038
[TBL] [Abstract][Full Text] [Related]
22. Prognostic and predictive value of cathepsins D and L in operable breast cancer patients.
Jagodic M; Vrhovec I; Borstnar S; Cufer T
Neoplasma; 2005; 52(1):1-9. PubMed ID: 15739019
[TBL] [Abstract][Full Text] [Related]
23. Cysteine protease activities and tumor development in human colorectal carcinoma.
Sheahan K; Shuja S; Murnane MJ
Cancer Res; 1989 Jul; 49(14):3809-14. PubMed ID: 2544258
[TBL] [Abstract][Full Text] [Related]
24. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue.
Friedrich B; Jung K; Lein M; Türk I; Rudolph B; Hampel G; Schnorr D; Loening SA
Eur J Cancer; 1999 Jan; 35(1):138-44. PubMed ID: 10211102
[TBL] [Abstract][Full Text] [Related]
25. Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico-pathological parameters.
Adenis A; Huet G; Zerimech F; Hecquet B; Balduyck M; Peyrat JP
Cancer Lett; 1995 Sep; 96(2):267-75. PubMed ID: 7585467
[TBL] [Abstract][Full Text] [Related]
26. Lysosomal cathepsins B and L and Stefin A blood levels in patients with hepatocellular carcinoma and/or liver cirrhosis: potential clinical implications.
Leto G; Tumminello FM; Pizzolanti G; Montalto G; Soresi M; Gebbia N
Oncology; 1997; 54(1):79-83. PubMed ID: 8978598
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients.
Shimada R; Iinuma H; Akahane T; Horiuchi A; Watanabe T
Oncol Rep; 2012 Apr; 27(4):947-53. PubMed ID: 22267181
[TBL] [Abstract][Full Text] [Related]
28. Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease.
Azaryan AV; Hook VY
Arch Biochem Biophys; 1994 Oct; 314(1):171-7. PubMed ID: 7944391
[TBL] [Abstract][Full Text] [Related]
29. [Role and behavior of cathepsin B and cathepsin L in gastric cancer].
Herszényi L; Plebani M; Carraro P; De Paoli M; Roveroni G; Rugge M; Cardin R; Naccarato R; Farinati F
Orv Hetil; 1995 Jun; 136(25):1315-8. PubMed ID: 7596589
[TBL] [Abstract][Full Text] [Related]
30. Localization of nuclear cathepsin L and its association with disease progression and poor outcome in colorectal cancer.
Sullivan S; Tosetto M; Kevans D; Coss A; Wang L; O'Donoghue D; Hyland J; Sheahan K; Mulcahy H; O'Sullivan J
Int J Cancer; 2009 Jul; 125(1):54-61. PubMed ID: 19291794
[TBL] [Abstract][Full Text] [Related]
31. Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients.
Levicar N; Kos J; Blejec A; Golouh R; Vrhovec I; Frkovic-Grazio S; Lah TT
Cancer Detect Prev; 2002; 26(1):42-9. PubMed ID: 12088202
[TBL] [Abstract][Full Text] [Related]
32. Cathepsin L in glioma progression: comparison with cathepsin B.
Strojnik T; Kavalar R; Trinkaus M; Lah TT
Cancer Detect Prev; 2005; 29(5):448-55. PubMed ID: 16183211
[TBL] [Abstract][Full Text] [Related]
33. Cathepsins B, H and L in human breast carcinoma.
Gabrijelcic D; Svetic B; Spaić D; Skrk J; Budihna M; Dolenc I; Popovic T; Cotic V; Turk V
Eur J Clin Chem Clin Biochem; 1992 Feb; 30(2):69-74. PubMed ID: 1316176
[TBL] [Abstract][Full Text] [Related]
34. Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis.
Lah TT; Kalman E; Najjar D; Gorodetsky E; Brennan P; Somers R; Daskal I
Hum Pathol; 2000 Feb; 31(2):149-60. PubMed ID: 10685628
[TBL] [Abstract][Full Text] [Related]
35. Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer.
Louhimo J; Carpelan-Holmström M; Alfthan H; Stenman UH; Järvinen HJ; Haglund C
Int J Cancer; 2002 Oct; 101(6):545-8. PubMed ID: 12237895
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma.
Diez M; Cerdán FJ; Pollán M; Maestro ML; Ortega MD; Martínez S; Moreno G; Balibrea JL
Anticancer Res; 1994; 14(6B):2819-25. PubMed ID: 7872725
[TBL] [Abstract][Full Text] [Related]
37. Levels of serum cathepsin L and several glycosidases in patients operated for colorectal cancer.
Sánchez-Martín MM; Cabezas JA; Ortega S; García J; García-Criado FJ; Pina J; Gómez-Alonso A
Cancer Lett; 1999 Jul; 141(1-2):73-7. PubMed ID: 10454245
[TBL] [Abstract][Full Text] [Related]
38. Characterizing human colorectal carcinomas by proteolytic profile.
Murnane MJ; Shuja S; Del Re E; Cai J; Iacobuzio-Donahue C; Klepeis V
In Vivo; 1997; 11(3):209-16. PubMed ID: 9239513
[TBL] [Abstract][Full Text] [Related]
39. Lysosomal cysteine proteinases in rat epididymis.
Tomomasa H; Waguri S; Umeda T; Koiso K; Kominami E; Uchiyama Y
J Histochem Cytochem; 1994 Mar; 42(3):417-25. PubMed ID: 8308258
[TBL] [Abstract][Full Text] [Related]
40. Determination of cathepsins B and H in sera and synovial fluids of patients with different joint diseases.
Gabrijelcic D; Annan-Prah A; Rodic B; Rozman B; Cotic V; Turk V
J Clin Chem Clin Biochem; 1990 Mar; 28(3):149-53. PubMed ID: 2329322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
